NGUYET NGUYEN: Open Payments
NPI 1083143093 · MIDLOTHIAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,183 in 172 payments from 22 companies in 2025. Trend: 2023 $3,488 · 2024 $3,828 · 2025 $4,183
Food & beverage: $3,957Education: $226
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 24 | $487 |
| Galderma Laboratories, L.P. | 12 | $409 |
| UCB, Inc. | 14 | $359 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $343 |
| ABBVIE INC. | 11 | $292 |
| Amgen Inc. | 9 | $226 |
| Janssen Biotech, Inc. | 2 | $225 |
| Arcutis Biotherapeutics, Inc. | 6 | $210 |
| E.R. Squibb & Sons, L.L.C. | 16 | $195 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $179 |
Products named: NUZYRA, NEMLUVIO, Bimzelx, DUPIXENT, OTEZLA, TREMFYA, Winlevi, RINVOQ.
Industry payments across TX — which companies pay providers there.
